import{_ as t}from"./plugin-vue_export-helper-DlAUqK2U.js";import{c as o,a as r,o as a}from"./app-CqK2vvZS.js";const i={};function n(d,e){return a(),o("div",null,e[0]||(e[0]=[r('<p>Health regulators are being <code>urged</code> to <code>rapidly</code> approve two gamechanging <code>dementia</code> <code>drugs</code> in order to ensure millions of people who could benefit are not left in <code>limbo</code>, after more stunning trial data. The final results from a <code>landmark</code> study confirmed that donanemab, made by Eli Lilly, slowed <code>cognitive</code> decline in Alzheimer’s patients by 35%. Trial results published last year showed that a second drug, lecanemab, made by Eisai and Biogen, reduced the rate by 27%. Health leaders <code>hailed</code> the arrival of the drugs as a turning point in the fight against Alzheimer’s, through which the disease could become just as manageable as conditions such as <code>diabetes</code> or <code>asthma</code>.</p><div class="hint-container tip"><p class="hint-container-title">tips</p><p>urge：极力主张；迫切要求</p><p>dementia：痴呆</p><p>dement：使发狂（ment- = mind，思考，神智）</p><p>limbo：处于不定状态</p><p>landmark：划时代的事，里程碑</p><p>cognitive：认知的</p><p>hail：打招呼；冰雹；赞扬</p><p>diabetes：糖尿病</p><p>asthma：哮喘病</p></div>',2)]))}const s=t(i,[["render",n],["__file","2307200601.html.vue"]]),c=JSON.parse('{"path":"/english/everyday/2023/2307200601.html","title":"Experts urge health regulators to approve \\"turning point\\" dementia drugs","lang":"zh-CN","frontmatter":{"title":"Experts urge health regulators to approve \\"turning point\\" dementia drugs","date":"2023-07-19T22:01:00.000Z","category":"英文","tag":["everyday"],"description":"Health regulators are being urged to rapidly approve two gamechanging dementia drugs in order to ensure millions of people who could benefit are not left in limbo, after more st...","head":[["meta",{"property":"og:url","content":"https://blog.ruizhou.cf/english/everyday/2023/2307200601.html"}],["meta",{"property":"og:site_name","content":"rz blog"}],["meta",{"property":"og:title","content":"Experts urge health regulators to approve \\"turning point\\" dementia drugs"}],["meta",{"property":"og:description","content":"Health regulators are being urged to rapidly approve two gamechanging dementia drugs in order to ensure millions of people who could benefit are not left in limbo, after more st..."}],["meta",{"property":"og:type","content":"article"}],["meta",{"property":"og:locale","content":"zh-CN"}],["meta",{"property":"og:updated_time","content":"2024-01-23T11:30:36.000Z"}],["meta",{"property":"article:tag","content":"everyday"}],["meta",{"property":"article:published_time","content":"2023-07-19T22:01:00.000Z"}],["meta",{"property":"article:modified_time","content":"2024-01-23T11:30:36.000Z"}],["script",{"type":"application/ld+json"},"{\\"@context\\":\\"https://schema.org\\",\\"@type\\":\\"Article\\",\\"headline\\":\\"Experts urge health regulators to approve \\\\\\"turning point\\\\\\" dementia drugs\\",\\"image\\":[\\"\\"],\\"datePublished\\":\\"2023-07-19T22:01:00.000Z\\",\\"dateModified\\":\\"2024-01-23T11:30:36.000Z\\",\\"author\\":[{\\"@type\\":\\"Person\\",\\"name\\":\\"ruizhou\\",\\"url\\":\\"https://blog.ruizhou.cf\\"}]}"]]},"headers":[],"git":{"createdTime":1689873478000,"updatedTime":1706009436000,"contributors":[{"name":"liuruizhou","username":"liuruizhou","email":"liuruizhou@bilibili.com","commits":4,"url":"https://github.com/liuruizhou"}]},"readingTime":{"minutes":0.66,"words":197},"filePathRelative":"english/everyday/2023/2307200601.md","localizedDate":"2023年7月20日","excerpt":"","autoDesc":true}');export{s as comp,c as data};
